Compound OIY
Identifiers
- Canonical SMILES:
NCCC[C@H](N)CC(=O)NCCC[C@H](N)CC(=O)NCCC[C@H](N)CC(=O)N[C@@H]1[C@H](O)[C@@H](OC(N)=O)[C@@H](CO)O[C@H]1NC2=N[C@H]3[C@H](N2)[C@H](O)CNC3=O
- IUPAC name:
2-[(3S)-3-amino-6-{(3S)-3-amino-6-[(3S)-3,6-diaminohexanamido]hexanamido}hexanamido]-4-O-carbamoyl-2-deoxy-N-[(3aS,7R,7aS)-7-hydroxy-4-oxo-3a,4,5,6,7,7a-hexahydro-1H-imidazo[4,5-c]pyridin-2-yl]-beta-D-gulopyranosylamine - InChi:
InChI=1S/C31H58N12O10/c32-7-1-4-15(33)10-20(46)37-8-2-5-16(34)11-21(47)38-9-3-6-17(35)12-22(48)40-25-26(49)27(53-30(36)51)19(14-44)52-29(25)43-31-41-23-18(45)13-39-28(50)24(23)42-31/h15-19,23-27,29,44-45,49H,1-14,32-35H2,(H2,36,51)(H,37,46)(H,38,47)(H,39,50)(H,40,48)(H2,41,42,43)/t15-,16-,17-,18+,19+,23+,24-,25+,26-,27-,29+/m0/s1
- InChiKey:
WUJTXMVGXDQPNN-OTQKCRDJSA-N
- SMARTS:
[#7]-[#6]-[#6]-[#6]-[#6@H](-[#7])-[#6]-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]-[#6@H](-[#7])-[#6]-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]-[#6@H](-[#7])-[#6]-[#6](=[#8])-[#7]-[#6@@H]1-[#6@H](-[#8])-[#6@@H](-[#8]-[#6](-[#7])=[#8])-[#6@@H](-[#6]-[#8])-[#8]-[#6@H]-1-[#7]-[#6]1=[#7]-[#6@H]2-[#6@H](-[#7]-1)-[#6@H](-[#8])-[#6]-[#7]-[#6]-2=[#8]
Chemistry rules
| Lipinski's RO5 | Veber | Pfizer's 3/75 |
|---|---|---|
External links
RNA-SM complexes
Physicochemical filters
| Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
|---|---|---|---|---|
| Compliance | ||||
| MW | 758.44 g/mol | |||
| HBA | 17 | |||
| HBD | 14 | |||
| HBA + HBD | ||||
| AlogP | -6.53 | |||
| TPSA | 379.14 | |||
| RB | 21 |
49852376
CHEMBL4535777